Targeting the Epidermal Growth Factor Pathway as Therapy for Glioblastoma

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|7|1|65-77

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.7, Iss.1, 2011-02, pp. : 65-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developments in Epidermal Growth Factor Receptor-Targeting Therapy for Solid Tumors: Focus on Matuzumab (EMD 72000)

By Schiller Joan  

Cancer Investigation, Vol. 26, Iss. 1, 2007-12 ,pp. : 81-95

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel induces apoptosis and reduces proliferation by targeting epidermal growth factor receptor signaling pathway in oral cavity squamous cell carcinoma

By Hu Jing   Zhang Na   Wang Ronglin   Huang Fei   Li Guang  

Oncology Letters, Vol. 10, Iss. 4, 2015-10 ,pp. : 2378-2384

Spandidos Publications

Access to resources Recommend Favorite

Targeting the epidermal growth factor receptor: prognostic and clinical implications

By Herbst R.  

EJC Supplements, Vol. 1, Iss. 8, 2003-10 ,pp. : 9-15

Elsevier

Access to resources Recommend Favorite

Epidermal Growth Factor Pathway Signaling in Drosophila Embryogenesis: Tools for Understanding Cancer

By Lusk Jay B.   Lam Vanessa Y. M.   Tolwinski Nicholas S.  

Cancers, Vol. 9, Iss. 2, 2017-02 ,pp. : 16-16

MDPI

Access to resources Recommend Favorite

CD9 modulates proliferation of human glioblastoma cells via epidermal growth factor receptor signaling

By    

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 1381-1386

Spandidos Publications

Access to resources Recommend Favorite